December 26 , 2025
13 days
120
- The US FDA has now approved Accrufer, a prescription oral medicine, for children aged 10 years and older with iron deficiency.
- This offers a new, non-invasive treatment option that fits better into daily life.
- Iron deficiency is the most common cause of anaemia.
- This can result in persistent fatigue, reduced concentration, delayed growth, and poorer academic performance.
- Until now, Accrufer was approved only for adults, starting in 2019.

Post Views:
120